Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective. Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." 

Our Trials Hub provides a comprehensive list of more than 20 active clinical trials located in Bangladesh, Canada, Egypt, France, Israel, and the United States.

👉 UPDATE February 6, 2023: New study posted "A Phase 1, Single and Multiple Ascending Dose (SAD/MAD) Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of VYN201 in Healthy Volunteers and in Subjects with Non-Segmental Vitiligo (NSV)" from Vyne Therapeutics.

Our CEO Yan Valle analyzes and monitors the entire drug development landscape along with the trends shaping and driving the vitiligo market, and reports findings in Vitiligo Drug Pipeline Analysis and Market Insights.